Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +0.53% | +13.86% | -0.53% |
Jun. 06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.53% | 151M | |
+46.03% | 754B | |
+40.95% | 630B | |
-5.91% | 352B | |
+19.90% | 331B | |
+9.64% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+5.92% | 164B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- HC Wainwright Adjusts Price Target on I-Mab to $25 From $45, Maintains Buy Rating